Variant report
Variant | esv3474864 |
---|---|
Chromosome Location | chr11:93693504-93698702 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1105114 | chr11:93693511-93693512 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs565693536 | chr11:93693519-93693520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532986852 | chr11:93693547-93693548 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551383732 | chr11:93693590-93693591 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs570008645 | chr11:93693611-93693612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs12787402 | chr11:93693612-93693613 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs555544328 | chr11:93693615-93693616 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs11020617 | chr11:93693653-93693654 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs75603722 | chr11:93693685-93693686 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs72962891 | chr11:93693717-93693718 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
11 | rs553217946 | chr11:93693790-93693791 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs112943448 | chr11:93693812-93693813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs180887585 | chr11:93693822-93693823 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs556933513 | chr11:93693891-93693892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536329026 | chr11:93693894-93693895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs61906073 | chr11:93693913-93693914 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs542912539 | chr11:93693965-93693966 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs367799693 | chr11:93693971-93693972 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561547285 | chr11:93693978-93693979 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs528651605 | chr11:93694023-93694024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs540800651 | chr11:93694060-93694061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs559527953 | chr11:93694080-93694081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs371594492 | chr11:93694087-93694088 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs533052333 | chr11:93694110-93694111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs551396289 | chr11:93694154-93694155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569626615 | chr11:93694162-93694163 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs541426978 | chr11:93694200-93694201 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369111277 | chr11:93694202-93694203 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552479229 | chr11:93694210-93694211 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs546780865 | chr11:93694222-93694223 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs147209110 | chr11:93694254-93694255 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs140525799 | chr11:93694259-93694260 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs76756757 | chr11:93694272-93694273 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs375042361 | chr11:93694305-93694306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs184541464 | chr11:93694376-93694377 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546764622 | chr11:93694402-93694403 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149726069 | chr11:93694403-93694404 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs374096409 | chr11:93694405-93694406 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs544166994 | chr11:93694420-93694421 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs538700730 | chr11:93694471-93694472 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577599318 | chr11:93694475-93694476 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs189329493 | chr11:93694505-93694506 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs556488407 | chr11:93694522-93694523 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs144538771 | chr11:93694616-93694617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs148441984 | chr11:93694631-93694632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564060669 | chr11:93694655-93694656 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs142539723 | chr11:93694656-93694657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs12795609 | chr11:93694659-93694660 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs181542250 | chr11:93694694-93694695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs146426644 | chr11:93694706-93694707 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93692600-93694600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
2 | chr11:93693000-93693600 | Enhancers | Fetal Muscle Leg | muscle |
3 | chr11:93693400-93693600 | Enhancers | Pancreas | Pancrea |
4 | chr11:93694400-93696000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr11:93694600-93696400 | Enhancers | HMEC | breast |
6 | chr11:93694600-93696600 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
7 | chr11:93694800-93695200 | Enhancers | Fetal Lung | lung |
8 | chr11:93694800-93695600 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
9 | chr11:93695000-93695400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
10 | chr11:93695000-93695400 | Enhancers | NHEK | skin |
11 | chr11:93695000-93695600 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin03 | Skin |
12 | chr11:93695000-93696800 | Bivalent Enhancer | Foreskin Melanocyte Primary Cells skin01 | Skin |
13 | chr11:93695400-93695600 | Bivalent Enhancer | Fetal Adrenal Gland | Adrenal Gland |
14 | chr11:93695400-93696400 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
15 | chr11:93695600-93697000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr11:93695800-93696400 | Enhancers | K562 | blood |
17 | chr11:93696800-93697000 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |